MIM
IMA

Monashee Investment Management’s ImageneBio Inc IMA Stock Holding History

Monashee Investment Management’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-91,621
Closed -$632K – 51
2025
Q4 		$632K Buy
+91,621
New +$679K 0.36% 39

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Monashee Investment Management's IMA Position: Q1 2026 in Review

Monashee Investment Management sold out of ImageneBio Inc (IMA) in Q1 2026, closing a stake of 91,621 shares — an estimated $632K sold.

Monashee Investment Management first reported a position in IMA in Q4 2025 and held it in 1 quarter. The position peaked at $632K in Q4 2025. 39 funds tracked by Wall St. Rank hold IMA as of Q1 2026.

  • Monashee Investment Management reported no remaining ImageneBio Inc position as of Q1 2026 after selling out during the quarter.
  • Monashee Investment Management sold 91,621 ImageneBio Inc shares in Q1 2026, an estimated $632K.
  • Monashee Investment Management first reported a position in ImageneBio Inc in Q4 2025 and held it in 1 quarter.
  • Monashee Investment Management's ImageneBio Inc position peaked at $632K in Q4 2025.
  • 39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2026.

Based on Monashee Investment Management's 13F filing for Q1 2026, filed 13 May 2026.